Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.470
-0.010 (-0.68%)
Aug 14, 2025, 1:45 PM - Market open
Envoy Medical Revenue
Envoy Medical had revenue of $78.00K in the quarter ending June 30, 2025, with 14.71% growth. This brings the company's revenue in the last twelve months to $222.00K, down -26.49% year-over-year. In the year 2024, Envoy Medical had annual revenue of $225.00K, down -28.80%.
Revenue (ttm)
$222.00K
Revenue Growth
-26.49%
P/S Ratio
134.46
Revenue / Employee
$5,286
Employees
42
Market Cap
31.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 225.00K | -91.00K | -28.80% |
Dec 31, 2023 | 316.00K | 79.00K | 33.33% |
Dec 31, 2022 | 237.00K | -73.00K | -23.55% |
Dec 31, 2021 | 310.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCOCH News
- 14 days ago - Envoy Medical Reports on Second Quarter 2025 Results - Newsfile Corp
- 5 weeks ago - Envoy Medical Expands Patent Portfolio with New Issuances in the United States - Newsfile Corp
- 6 weeks ago - Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia - Newsfile Corp
- 7 weeks ago - New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical - Newsfile Corp
- 2 months ago - Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th - GlobeNewsWire
- 2 months ago - Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up - Newsfile Corp
- 3 months ago - Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial - Newsfile Corp
- 3 months ago - Envoy Medical Reports on First Quarter 2025 Results - Newsfile Corp